
A vaccine for leprosy, developed by the Infectious Disease Research Institute (IDRI) and with the financial support of the American …

Ardelyx has confirmed that its NHE3 inhibitor tenapanor met all its primary and secondary endpoints in the study of its …

Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness, details the lessons learned from the Ebola outbreak and the …

In a preliminary review of the drug, the FDA has judged that Aerie Pharmaceutical’s experimental glaucoma treatment Rhopressa (netarsudil) effectively …

MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …

Sanofi has announced that it plans to expand its vaccine manufacturing facility in Val de Reuil, France, with an injection …

An analysis of childhood and teenage obesity levels around the world have revealed that the numbers who are considered dangerously …

The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …

Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the …

It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …

NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill …

A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid …

The Scottish government, on Mental Health Day, has revealed that it will boost spending on mental health services by £500,000. …

In a move that is guaranteed to result in further lawsuits and acrimony, California has signed into law a requirement …

A new report emerging from the Institute of Directors placed UK pharma giant, GSK, in last place out of 103 …